FluoroType MTBDR 检测肺及肺外样本中结核分枝杆菌复合群
研究评估 FluoroType MTBDR 实时 PCR 在单次反应中同时检测 MTBC 及 INH/RIF 耐药突变的可行性,分析 3885 份连续原代样本并与镜检和培养比较。总体灵敏度 0.714、特异度 0.996,痰标本灵敏度 0.854;139 份 MTBC 阳性中 99 份(71%)至少一种药物获得可解释耐药结果。
要点
- FT-MTBDR 单次 PCR 可同时检测 MTBC 及 INH/RIF 耐药突变
- 痰标本灵敏度 0.854,总体灵敏度 0.714,特异度 0.996
- MTBC 阳性中 71% 至少一种药物获得可解释基因型耐药结果
核心结论
- FT-MTBDR 检测 MTBC 能力 adequate,并具有单次 PCR 同时检测 INH 和 RIF 基因型耐药的显著附加特征。
研究设计与样本
- 连续分析 3885 份原代样本,其中痰 978 份、其他呼吸道部位加胃灌洗液 2007 份、肺外部位 875 份,与镜检和培养比较。
主要发现
- 176 份培养 MTBC 阳性,139 份 FT-MTBDR 阳性,灵敏度 0.714(95%CI 0.640-0.779),特异度 0.996(95%CI 0.994-0.998)。
- 978 份痰中 96 份培养阳性、89 份 FT-MTBDR 阳性,灵敏度 0.854(95%CI 0.764-0.915),特异度 0.992(95%CI 0.983-0.997)。
- 139 份 MTBC 阳性中,99 份(71%)至少一种药物获得可解释基因型耐药结果,92 份(66%)两种药物均获得。
临床怎么用
- FT-MTBDR 可作为 MTBC 检测并同步提供 INH 和 RIF 耐药信息的单次 PCR 方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Rifampicin (RIF) and isoniazid (INH) are the two most effective first-line antibiotic drugs for the treatment of tuberculosis (TB). The new FluoroType MTBDR (FT-MTBDR) real-time PCR is intended to detect INH and RIF resistance mutations as a second step following a primary Mycobacterium tuberculosis complex (MTBC) PCR. Here we evaluate the feasibility of the FT-MTBDR assay to detect simultaneously MTBC-specific DNA as well as to detect potential INH and RIF resistance through analysing inhA promotor, katG and rpoB sequences in one PCR reaction. METHODS: We analysed 3885 consecutive primary samples with FT-MTBDR and compared the results with microscopy and culture: 978 were from sputum, 2007 from other respiratory tract locations plus gastric lavages, and 875 from extrapulmonary locations, respectively. RESULTS: Overall, 176 samples were MTBC culture positive and 139 FT-MTBDR positive, providing a FT-MTBDR sensitivity of 0.714 (95% confidence interval 0.640-0.779) and specificity of 0.996 (0.994-0.998), respectively. For the 978 sputum, 96 were MTBC culture positive and 89 FT-MTBDR positive, sensitivity 0.854 (0.764-0.915) and specificity 0.992 (0.983-0.997). Of the 139 MTBC positive, 99 (71%) had interpretable genotypic resistance results for at least one drug, 92 (66%) for both drugs. DISCUSSION: The ability of FT-MTBDR to detect MTBC is adequate with the significant added feature of simultaneous genotypic resistance detection of both INH and RIF in a single PCR reaction.
引用
- Svensson E, Folkvardsen DB, Rasmussen EM, et al. Detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary samples with the FluoroType MTBDR assay. Clin Microbiol Infect. 2021. PMID: 33421581. doi:10.1016/j.cmi.2020.12.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。